Azenta Price to Free Cash Flow Ratio 2010-2023 | AZTA
Historical price to free cash flow ratio values for Azenta (AZTA) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Azenta Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-05-02 | 52.57 | 110.86 | |
| 2023-12-31 | 65.14 | $0.47 | 137.37 |
| 2023-09-30 | 50.19 | $-0.33 | 0.00 |
| 2023-06-30 | 46.68 | $-0.88 | 0.00 |
| 2023-03-31 | 44.62 | $-6.75 | 0.00 |
| 2022-12-31 | 58.22 | $-7.72 | 0.00 |
| 2022-09-30 | 42.86 | $-7.20 | 0.00 |
| 2022-06-30 | 72.10 | $-7.02 | 0.00 |
| 2022-03-31 | 82.88 | $-0.74 | 0.00 |
| 2021-12-31 | 103.11 | $0.88 | 117.01 |
| 2021-09-30 | 102.26 | $1.30 | 78.53 |
| 2021-06-30 | 95.08 | $1.75 | 54.37 |
| 2021-03-31 | 81.40 | $1.51 | 53.99 |
| 2020-12-31 | 67.55 | $0.14 | 493.80 |
| 2020-09-30 | 45.99 | $-0.03 | 0.00 |
| 2020-06-30 | 43.89 | $-0.25 | 0.00 |
| 2020-03-31 | 30.19 | $-0.08 | 0.00 |
| 2019-12-31 | 41.42 | $1.11 | 37.39 |
| 2019-09-30 | 36.46 | $0.93 | 39.37 |
| 2019-06-30 | 38.05 | $0.98 | 38.81 |
| 2019-03-31 | 28.73 | $0.78 | 36.61 |
| 2018-12-31 | 25.56 | $0.89 | 28.64 |
| 2018-09-30 | 34.08 | $0.87 | 39.39 |
| 2018-06-30 | 31.65 | $0.88 | 35.79 |
| 2018-03-31 | 26.19 | $0.90 | 29.24 |
| 2017-12-31 | 22.98 | $0.98 | 23.41 |
| 2017-09-30 | 29.14 | $1.19 | 24.58 |
| 2017-06-30 | 20.74 | $1.11 | 18.70 |
| 2017-03-31 | 21.34 | $1.06 | 20.17 |
| 2016-12-31 | 16.19 | $0.86 | 18.76 |
| 2016-09-30 | 12.83 | $0.43 | 29.78 |
| 2016-06-30 | 10.49 | $0.27 | 38.47 |
| 2016-03-31 | 9.64 | $0.30 | 32.15 |
| 2015-12-31 | 9.80 | $0.16 | 60.30 |
| 2015-09-30 | 10.65 | $0.40 | 26.47 |
| 2015-06-30 | 10.32 | $0.39 | 26.20 |
| 2015-03-31 | 10.39 | $0.24 | 42.49 |
| 2014-12-31 | 11.29 | $0.62 | 18.10 |
| 2014-09-30 | 9.23 | $0.71 | 12.94 |
| 2014-06-30 | 9.38 | $1.08 | 8.69 |
| 2014-03-31 | 9.44 | $1.21 | 7.83 |
| 2013-12-31 | 8.99 | $1.03 | 8.76 |
| 2013-09-30 | 7.92 | $0.98 | 8.05 |
| 2013-06-30 | 8.20 | $0.47 | 17.46 |
| 2013-03-31 | 8.51 | $0.42 | 20.28 |
| 2012-12-31 | 6.68 | $0.44 | 15.24 |
| 2012-09-30 | 6.60 | $0.42 | 15.83 |
| 2012-06-30 | 7.67 | $0.61 | 12.53 |
| 2012-03-31 | 9.94 | $0.96 | 10.32 |
| 2011-12-31 | 8.22 | $1.05 | 7.85 |
| 2011-09-30 | 6.47 | $1.25 | 5.18 |
| 2011-06-30 | 8.55 | $2.49 | 3.43 |
| 2011-03-31 | 10.81 | $1.92 | 5.62 |
| 2010-12-31 | 7.14 | $1.36 | 5.25 |
| 2010-09-30 | 5.28 | $0.25 | 20.79 |
| 2009-09-30 | 6.09 | $-1.33 | 0.00 |
| 2009-06-30 | 3.53 | $-1.01 | 0.00 |
| 2009-03-31 | 3.63 | $-0.73 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.905B | $0.665B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
| Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
| Axonics (AXNX) | United States | $3.412B | 0.00 |
| 10x Genomics (TXG) | United States | $3.208B | 0.00 |
| Enovis (ENOV) | United States | $3.038B | 23.08 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 94.89 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.53 |
| Phreesia (PHR) | United States | $1.185B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
| Talkspace (TALK) | United States | $0.536B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Outset Medical (OM) | United States | $0.147B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| Augmedix (AUGX) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.04 |
| 111 (YI) | China | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.048B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |